AfGin Pharma


AfGin Pharma is a biopharmaceutical research and development company focused on topical delivery of neuro-active drugs via peripheral nerve pathways to access central nervous system targets. The company develops and commercializes topical formulations, pursues preclinical and clinical development, and maintains an intellectual property portfolio across multiple jurisdictions.

Industries

biotechnology
health-care
manufacturing
pharmaceutical

Nr. of Employees

small (1-50)

AfGin Pharma

Sarasota, Florida, United States, North America


Products

Topical migraine formulation (consumer topical product)

A topical formulation intended for migraine symptom relief, distributed for consumer use across multiple U.S. states.


Services

Preclinical and clinical development of topical neuroactive therapies

Support for preclinical and clinical advancement of topical formulations targeting neurological indications.

Intellectual property strategy and patent portfolio development

Development and management of patent filings and portfolio strategy with access to specialized patent counsel.

Commercialization and distribution of topical products

Bringing topical migraine formulation to consumer markets and operating related subsidiaries for market deployment.

Expertise Areas

  • Topical neuroactive drug delivery
  • Clinical development and investigator-led studies
  • Neurology and neuropsychiatry therapeutic areas
  • Formulation development and compounding for topical products
  • Show More (2)

Key Technologies

  • Topical nerve-targeted drug delivery
  • Peripheral nerve pathway CNS targeting
  • Topical formulation development for neuro-active agents
  • Investigator-led clinical trial conduct
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.